Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-23T21:11:10.329Z Has data issue: false hasContentIssue false
  • English
  • Français

Is there a gender difference in the effect of antioxidants on cancer risk?

Published online by Cambridge University Press:  08 March 2007

Jane V. Higdon  and
Balz Frei
Jane V. Higdon
Affiliation:
Linus Pauling Institute, Oregon State University, Corvallis OR 97331-6512, USA
Balz Frei
Affiliation:
Linus Pauling Institute, Oregon State University, Corvallis OR 97331-6512, USA
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Invited commentary
Information
British Journal of Nutrition , Volume 94 , Issue 2 , August 2005 , pp. 139 - 140
Copyright
Copyright © The Nutrition Society 2005

References

Blot, WJ, Li, JY & Taylor, PR (1993) Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 85, 1483–1492.CrossRefGoogle ScholarPubMed
Cook, NR, Stampfer, MJ, Ma, J, Manson, JE, Sacks, FM, Buring, JE & Hennekens, CH (1999) β-Carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer 86, 1783–1792.3.0.CO;2-N>CrossRefGoogle ScholarPubMed
Duffield-Lillico, AJ, Dalkin, BL, Reid, ME, Turnbull, BW, Slate, EH, Jacobs, ET, Marshall, JR & Clark, LC (2003) Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 91, 608–612.CrossRefGoogle ScholarPubMed
Eichholzer, M, Stahelin, HB, Gey, KF, Ludin, E & Bernasconi, F (1996) Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int J Cancer 66, 145–150.3.0.CO;2-2>CrossRefGoogle ScholarPubMed
Galan, P, Briançon, S & Favier, A (2005) Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels?. Br J Nutr 94, 125–132.CrossRefGoogle Scholar
Heinonen, OP, Albanes, D & Virtamo, J (1998) Prostate cancer and supplementation with α-tocopherol and β-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 90, 440–446.CrossRefGoogle ScholarPubMed
Helzlsouer, KJ, Huang, HY, Alberg, AJ, Hoffman, S, Burke, A, Norkus, EP, Morris, JS & Comstock, GW (2000) Association between α-tocopherol, γ-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 92, 2018–2023.CrossRefGoogle ScholarPubMed
Hercberg, S, Galan, P, Preziosi, P, Bertrais, S, Mennen, L, Malvy, D, Roussel, AM, Favier, A & Briancon, S (2004) The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164, 2335–2342.CrossRefGoogle ScholarPubMed
Higdon, J & Frei, B (2005) Vitamin C vitamin E, and β-carotene in cancer chemoprevention. In Phytopharmaceuticals in Cancer Chemoprevention, pp. 271–309[Bagchi, D and Preuss, H, editors]. Boca Raton, FL: CRC Press.Google Scholar
Khaw, KT, Bingham, S, Welch, A, Luben, R, Wareham, N, Oakes, S & Day, N (2001) Relation between plasma ascorbic acid and mortality in men and women in EPIC–Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition. Lancet 357, 657–663.CrossRefGoogle ScholarPubMed
Loria, CM, Klag, MJ, Caulfield, LE & Whelton, PK (2000) Vitamin C status and mortality in US adults. Am J Clin Nutr 72, 139–145.CrossRefGoogle ScholarPubMed
Moller, P & Loft, S (2004) Interventions with antioxidants and nutrients in relation to oxidative DNA damage and repair. Mutat Res 551, 79–89.CrossRefGoogle ScholarPubMed
Simon, JA, Hudes, ES & Tice, JA (2001) Relation of serum ascorbic acid to mortality among US adults. J Am Coll Nutr 20, 255–263.CrossRefGoogle ScholarPubMed
Tamimi, RM, Hankinson, SE, Campos, H, Spiegelman, D, Zhang, S, Colditz, GA, Willett, WC & Hunter, DJ (2005) Plasma carotenoids, retinol, and tocopherols and risk of breast cancer. Am J Epidemiol 161, 153–160.CrossRefGoogle ScholarPubMed
Waters, DJ, Chiang, EC, Cooley, DM & Morris, JS (2004) Making sense of sex and supplements: differences in the anticarcinogenic effects of selenium in men and women. Mutat Res 551, 91–107.CrossRefGoogle ScholarPubMed
Weinstein, SJ, Wright, ME, Pietinen, P, King, I, Tan, C, Taylor, PR, Virtamo, J & Albanes, D (2005) Serum α-tocopherol and γ-tocopherol in relation to prostate cancer risk in a prospective study. J Natl Cancer Inst 97, 396–399.CrossRefGoogle ScholarPubMed
Woodall, AA & Ames, BN (1997) Diet and oxidative damage to DNA: the importance of ascorbate as an antioxidant. In Vitamin C in Health and Disease, pp. 193–204 [Packer, L and Fuchs, J, editors]. New York: Marcel Dekker.Google Scholar